Table 1.
Patients’ characteristics and perioperative outcomes
| Patients With Intestinal Crohn’s Disease (n=166) | |
|---|---|
| Gender* | |
| Female | 78 (47) |
| Male | 88 (53) |
|
| |
| Age# | 36±11.5 |
|
| |
| ASA* | |
| I | 125 (75) |
| II | 40 (24) |
| III | 1 (1) |
|
| |
| Disease site* | |
| Ileocecal region | 109 (66) |
| Large bowel | 35 (21) |
| Small bowel | 11 (7) |
| De novo Crohn’s disease | 11 (7) |
|
| |
| Indication for surgery* | |
| Stricturing | 92 (55) |
| Fistulizing | 45 (27) |
| Inflammatory | 12 (7) |
| De novo Crohn’s disease | 11 (7) |
| Right colon cancer | 3 (2) |
| Toxic colitis | 3 (2) |
|
| |
| Medical treatment* | |
| AZA | 70 (42) |
| Corticosteroid | 19 (12) |
| Anti-TNFα | 10 (6) |
| MTX | 2 (1) |
| 6-MP | 2 (1) |
| Non-regular (non-compliance with) medical treatment | 63 (38) |
|
| |
| Operative approach* | |
| Open | 104 (63) |
| Laparoscopic | 56 (34) |
| Laparoscopic to open | 2 (1) |
| Robotic | 4 (3) |
|
| |
| Operative procedures* | |
| Ileocecal resection | 109 (65) |
| Colon resection | 35 (21) |
| Small bowel resection | 11 (7) |
| Restorative proctocolectomy | 11 (7) |
|
| |
| Early (<30 day) complications* | |
| Anastomotic leak | 10 (6) |
| Intra-abdominal bleeding | 2 (1) |
| Stoma-related complication | 2 (1) |
| Acute mechanical intestinal obstruction | 1 (0.6) |
| Wound infection | 11 (7) |
|
| |
| Late complications* | |
| Incisional hernia | 2 (1) |
| Intestinal obstruction | 2 (1) |
|
| |
| Mortality* | |
| Renal failure | 2 (1) |
| Electrolyte imbalance | 1 (0.6) |
| Epileptic seizure | 1 (0.6) |
Continuous variables are described as the mean±standard deviation; categorical variables are described as n (%)
ASA: American Society of Anesthesiologists; AZA: azathioprine; Anti-TNFα: anti-tumor necrosis factor alpha; MTX: methotrexate; 6-MP: 6-mercaptopurine
*
n (%)
#
mean±SD